Netris pancreatic cancer study doses first patient
Company’s candidate NP137 combined with mFOLFIRINOX will be researched during vital trials - News - PharmaTimes
Source: pharmatimes.com
📰 Netris News
Netris News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Netris . Real-time updates on events, politics, business and more.
Netris Pharma starts hepatocellular carcinoma study
Trial will evaluate efficacy of anti-netrin-1 antibody candidate NP137 in combination with Atezo-bev - News - PharmaTimes
Source: pharmatimes.com